Subscribe
shutterstock_1932588389_marvent
marvent / Shutterstock.com
15 November 2022FeaturesBiotechnologyJanine Swarbrick and Sofie McPherson

Promoting women in STEM

Historically, professions in science and law have been dominated by men, but how does this industry look in 2022? Are women really at the heart of it? Why should they be there? And what more could be done to support women in their careers in this field?

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

article
Women in STEM: Bridging the gender gap
21 May 2019   A plethora of studies have indicated that diversity drives innovation and economic performance, so why are the STEM fields, where innovation is the life-blood, so behind on gender diversity? WIPR investigates the reasons behind the failure to attract and retain women, and what needs to be done.
Biotechnology
UN International Day of Women and Girls in Science: a perspective
10 February 2022   Chiara Banas, patent scientist at EIP, queries the gender gap in life sciences, and shares how her own experiences could prefigure change.
Biotechnology
Femtech: from taboo to multibillion-dollar industry
7 September 2023   Technology is continuing to transform women’s healthcare and female inventors are driving the change—but more needs to be done to ensure they secure IP rights.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

article
Women in STEM: Bridging the gender gap
21 May 2019   A plethora of studies have indicated that diversity drives innovation and economic performance, so why are the STEM fields, where innovation is the life-blood, so behind on gender diversity? WIPR investigates the reasons behind the failure to attract and retain women, and what needs to be done.
Biotechnology
UN International Day of Women and Girls in Science: a perspective
10 February 2022   Chiara Banas, patent scientist at EIP, queries the gender gap in life sciences, and shares how her own experiences could prefigure change.
Biotechnology
Femtech: from taboo to multibillion-dollar industry
7 September 2023   Technology is continuing to transform women’s healthcare and female inventors are driving the change—but more needs to be done to ensure they secure IP rights.

More on this story

article
Women in STEM: Bridging the gender gap
21 May 2019   A plethora of studies have indicated that diversity drives innovation and economic performance, so why are the STEM fields, where innovation is the life-blood, so behind on gender diversity? WIPR investigates the reasons behind the failure to attract and retain women, and what needs to be done.
Biotechnology
UN International Day of Women and Girls in Science: a perspective
10 February 2022   Chiara Banas, patent scientist at EIP, queries the gender gap in life sciences, and shares how her own experiences could prefigure change.
Biotechnology
Femtech: from taboo to multibillion-dollar industry
7 September 2023   Technology is continuing to transform women’s healthcare and female inventors are driving the change—but more needs to be done to ensure they secure IP rights.

More features

Sarepta wins $115M in patent dispute over muscular dystrophy drug
CREATES Act unfairly tips the scales to generics
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York
Judge denies Intellia bid to throw out suit over $100m Regeneron pact
Trump’s return sparks calls for pro-patent agenda
Amgen faces pushback over bid to narrow patent scope
Gene tech firm fends off injunction in test kit dispute